Skip to main content
. 2023 Feb 16;28:249–263. doi: 10.1016/j.omto.2023.02.004

Figure 4.

Figure 4

In vivo expression of EGFRvIII-DBTE

(A) T cell-mediated cytotoxicity assay against U87vIII cells using NSG mouse sera treated with a single injection (100 μg) of pVAX1, EGFRvIII-DBTE, or recombinant EGFRvIIIxCD3 antibody. (B) T cell-mediated cytotoxicity assay against U87vIII cells using NSG mouse sera treated with various doses of EGFRvIII-DBTE. % Cytolysis data after 48-h incubation were plotted for both (A) and (B).